Title
Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers
Authoring Organizations
Publication Month/Year
April 18, 2016
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Target Patient Population
Female patients who are being considered for, or who are receiving, systemic therapy after definitive surgery for early invasive breast cancer
Target Provider Population
Medical oncologists, pathologists, surgeons, oncology nurses, patients, and caregivers.
Inclusion Criteria
Female, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Management, Treatment
Keywords
chemotherapy, Adjuvant Therapy, HER2, HER2 Positive, HER2 Negative
Source Citation
DOI: 10.1200/JCO.2016.67.0182 Journal of Clinical Oncology 34, no. 20 (July 10, 2016) 2416-2427.